IP Library Granted Patent US 12,269,796
Granted Patent B2
US 12,269,796 · App. 18/501,076 · Granted Apr 8, 2025

Isomerization of linear olefins with solid acid catalysts and primary esters

Inventor: Jeffery C Gee (Kingwood, TX)
Assignee: Chevron Phillips Chemical Company LP
C07C5/2568B01J31/10C07C11/02B01J2231/52C07C2531/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,269,796
App. No.
18/501,076
Granted
Apr 8, 2025
Kind
B2
Abstract

Isomerized olefin products are produced by contacting an olefin feed containing a C 10 to C 20 normal alpha olefin, a solid acid catalyst, and a C 2 to C 15 primary ester to form the isomerized olefin product. Typical primary esters used in the processes include formates and acetates. Linear olefin compositions are produced that contain at least 80 wt. % C 10 to C 20 linear internal olefins, less than 8 wt. % C 10 to C 20 normal alpha olefins, less than 8 wt. % dimers of C 10 to C 20 olefins, less than 15 wt. % C 10 to C 20 branched olefins, and at least 1 wt. % C 2 to C 15 primary ester and less than 8 wt. % secondary esters.

Claims (32)

1. A linear internal olefin composition comprising:

(a) at least 80 wt. % C 10 to C 20 linear internal olefins;

(b) less than or equal to 8 wt. % C 10 to C 20 normal alpha olefin;

(c) less than or equal to 8 wt. % dimers of C 10 to C 20 olefins;

(d) less than or equal to 15 wt. % C 10 to C 20 branched olefins; and

(e) at least 1 wt. % C 2 to C 15 primary ester and less than or equal to 8 wt. % secondary esters.

2. The composition of claim 1 , wherein the composition comprises:

(a) at least 85 wt. % C 10 to C 20 linear internal olefins;

(b) less than or equal to 3 wt. % C 10 to C 20 normal alpha olefin; and

(c) less than or equal to 6 wt. % dimers of C 10 to C 20 olefins.

3. The composition of claim 1 , wherein the composition comprises (e) at least 2 wt. % C 2 to C 15 primary ester and less than or equal to 5 wt. % secondary esters.

4. The composition of claim 1 , wherein the normal alpha olefin has a boiling point that is at least 50° C. greater than that of the primary ester.

5. The composition of claim 1 , wherein the normal alpha olefin has a boiling point that is from 75 to 250° C. greater than that of the primary ester.

6. The composition of claim 1 , wherein the primary ester comprises methyl acetate, ethyl acetate, n-propyl acetate, n-butyl acetate, pentyl acetate, isoamyl acetate, hexyl acetate, heptyl acetate, octyl acetate, nonyl acetate, decyl acetate, methyl formate, ethyl formate, n-propyl formate, n-butyl formate, pentyl formate, isoamyl formate, hexyl formate, heptyl formate, octyl formate, nonyl formate, decyl formate, or any combination thereof.

7. The composition of claim 1 , wherein the primary ester comprises ethyl acetate.

8. The composition of claim 1 , wherein the linear internal olefins comprise a nearly equilibrium distribution of linear double bond isomers.

9. The composition of claim 1 , wherein the composition comprises (a) from 85 to 97 wt. % C 10 to C 20 linear internal olefins.

10. The composition of claim 1 , wherein the composition comprises (b) from 0.1 to 5 wt. % C 10 to C 20 normal alpha olefin.

11. The composition of claim 1 , wherein the composition comprises (c) from 0.1 to 5 wt. % dimers of C 10 to C 20 olefins.

12. The composition of claim 1 , wherein the composition comprises (d) from 0.5 to 7 wt. % C 10 to C 20 branched olefins.

13. The composition of claim 1 , wherein the composition comprises (e) from 1 to 20 wt. % C 2 to C 15 primary ester and from 0.1 to 5 wt. % secondary esters.

14. A linear internal olefin composition comprising:

(a) from 80 to 97 wt. % C 10 to C 20 linear internal olefins;

(b) from 0.1 to 8 wt. % C 10 to C 20 normal alpha olefin;

(c) from 0.1 to 8 wt. % dimers of C 10 to C 20 olefins;

(d) from 0.1 to 15 wt. % C 10 to C 20 branched olefins; and

(e) from 1 to 15 wt. % C 2 to C 15 primary ester and from 0.1 to 8 wt. % secondary esters.

15. The composition of claim 14 , wherein the normal alpha olefin has a boiling point that is at least 50° C. greater than that of the primary ester.

16. The composition of claim 14 , wherein the normal alpha olefin has a boiling point that is from 75 to 250° C. greater than that of the primary ester.

17. The composition of claim 14 , wherein the primary ester comprises methyl acetate, ethyl acetate, n-propyl acetate, n-butyl acetate, pentyl acetate, isoamyl acetate, hexyl acetate, heptyl acetate, octyl acetate, nonyl acetate, decyl acetate, methyl formate, ethyl formate, n-propyl formate, n-butyl formate, pentyl formate, isoamyl formate, hexyl formate, heptyl formate, octyl formate, nonyl formate, decyl formate, or any combination thereof.

18. The composition of claim 14 , wherein the primary ester comprises ethyl acetate.

19. The composition of claim 14 , wherein the linear internal olefins comprise a nearly equilibrium distribution of linear double bond isomers.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2024
From: GEE, JEFFERY C.
To: CHEVRON PHILLIPS CHEMICAL COMPANY LP
Reel/Frame 068392/0986 →
Continuity (2)
Division 17894212 · Aug 24, 2022
Related Publication 20240067589A1 · Feb 29, 2024
References Cited (12)
US 5936136A · Slaugh · 1999 [cited by examiner]
US 6018089A · Slaugh · 2000 [cited by examiner]
US 10519088B2 · Bertin · 2019 [cited by applicant]
US 11845717B1 · Gee · 2023 [cited by examiner]
US 20040249229A1 · Gee · 2004 [cited by examiner]
US 20090163757A1 · Gee · 2009 [cited by examiner]
US 20140171677A1 · Bertin · 2014 [cited by applicant]
US 20140179964A1 · Gee · 2014 [cited by examiner]
US 20160102037A1 · Bertin · 2016 [cited by applicant]
US 20240051900A1 · Gee · 2024 [cited by examiner]
WO 2014085393A1 · 2014 [cited by applicant]
International Search Report and Written Opinion issued in corresponding PCT Application No. PCT/US2023/072607, mailed on Dec. 12, 2023, 8 pp. [cited by applicant]